Torbjörn Karlsson

Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia

Vikman, Sofia; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Ingår i Upsala Journal of Medical Sciences, 2023

• DOI för Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia
• Ladda ner fulltext (pdf) av Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia

Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma

Hidman, Josefin; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Ingår i Upsala Journal of Medical Sciences, 2023

• DOI för Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma

Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma.

Hidman, Josefin; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Ingår i Acta Haematologica, s. 326-333, 2022

• DOI för Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma.

Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia

Larsson, Karin; Höglund, Martin; Larsson, Anders; Thulin, Måns et al.

Ingår i Growth Factors, s. 189-196, 2021

• DOI för Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia
• Ladda ner fulltext (pdf) av Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia

Falsely elevated thyroid-stimulating hormone results dueto Interference by M-component of IgG-lambda type

Larsson, Anders; Gåfvels, Mats; Karlsson, Torbjörn

Ingår i Case Reports in Oncology, s. 680-682, 2020

• DOI för Falsely elevated thyroid-stimulating hormone results dueto Interference by M-component of IgG-lambda type
• Ladda ner fulltext (pdf) av Falsely elevated thyroid-stimulating hormone results dueto Interference by M-component of IgG-lambda type

Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia

Vikman, Sofia; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Ingår i Upsala Journal of Medical Sciences, 2023

• DOI för Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia
• Ladda ner fulltext (pdf) av Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia

Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma

Hidman, Josefin; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Ingår i Upsala Journal of Medical Sciences, 2023

• DOI för Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma

Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma.

Hidman, Josefin; Larsson, Anders; Thulin, Måns; Karlsson, Torbjörn

Ingår i Acta Haematologica, s. 326-333, 2022

• DOI för Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma.

Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia

Larsson, Karin; Höglund, Martin; Larsson, Anders; Thulin, Måns et al.

Ingår i Growth Factors, s. 189-196, 2021

• DOI för Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia
• Ladda ner fulltext (pdf) av Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia

Falsely elevated thyroid-stimulating hormone results dueto Interference by M-component of IgG-lambda type

Larsson, Anders; Gåfvels, Mats; Karlsson, Torbjörn

Ingår i Case Reports in Oncology, s. 680-682, 2020

• DOI för Falsely elevated thyroid-stimulating hormone results dueto Interference by M-component of IgG-lambda type
• Ladda ner fulltext (pdf) av Falsely elevated thyroid-stimulating hormone results dueto Interference by M-component of IgG-lambda type

Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital

Karlsson, Torbjörn; Cherif, Honar

Ingår i Upsala Journal of Medical Sciences, s. 153-157, 2018

• DOI för Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital
• Ladda ner fulltext (pdf) av Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital

Evaluation of a competitive hepcidin ELISA assay in the differential diagnosis of iron deficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients

Karlsson, Torbjörn

Ingår i Journal of Inflammation, 2017

• DOI för Evaluation of a competitive hepcidin ELISA assay in the differential diagnosis of iron deficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients
• Ladda ner fulltext (pdf) av Evaluation of a competitive hepcidin ELISA assay in the differential diagnosis of iron deficiency anaemia with concurrent inflammation and anaemia of inflammation in elderly patients

Effect of intravenous iron supplementation on iron stores in non-anemic iron-deficient patients with hereditary hemorrhagic telangiectasia

Karlsson, Torbjörn; Cherif, Honar

Ingår i Hematology Reports, 2016

• DOI för Effect of intravenous iron supplementation on iron stores in non-anemic iron-deficient patients with hereditary hemorrhagic telangiectasia
• Ladda ner fulltext (pdf) av Effect of intravenous iron supplementation on iron stores in non-anemic iron-deficient patients with hereditary hemorrhagic telangiectasia

Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy

Hedenus, Michael; Karlsson, Torbjörn; Ludwig, Heinz; Rzychon, Beate et al.

Ingår i Medical Oncology, s. 302, 2014

• DOI för Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy
• Ladda ner fulltext (pdf) av Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy

Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia

Cherif, Honar; Karlsson, Torbjörn

Ingår i Upsala Journal of Medical Sciences, s. 350-353, 2014

• DOI för Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia

Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study

Hjorth, Martin; Hjertner, Oyvind; Knudsen, Lene Meldgaard; Gulbrandsen, Nina et al.

Ingår i European Journal of Haematology, s. 485-496, 2012

• DOI för Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Waage, Anders; Gimsing, Peter; Fayers, Peter; Abildgaard, Niels et al.

Ingår i Blood, s. 1405-1412, 2010

• DOI för Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma